Licensing Agreement to add MeMed BV™, Immune System Based Protein Signature Test for Distinguishing between Bacterial vs. Viral Infections, to the broad DiaSorin LIAISON Ò test menu, available on ...
– Milestone Achieved Through Growing Clinical Evidence Demonstrating Real-World Impact on Infection Management – – MeMed and Physicians Premier Celebrated Milestone Event in Corpus Christi, Texas – ...
MeMed, a leader in host-response diagnostics, announced today that several oral presentations at the upcoming American College of Emergency Physicians (ACEP) Scientific Assembly 2025 will showcase the ...
ANDOVER, Mass. & HAIFA, Israel--(BUSINESS WIRE)--MeMed, a leader in host-response diagnostics, today announced the addition of three distinguished experts to its advisory board to accelerate its ...
Israel’s MeMed Diagnostics, a Haifa-based medical tech firm that develops diagnostic solutions to monitor the body’s immune state, raised $93 million in a private financing round to help commercialize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results